Breast Cancer Drug Market to Achieve USD 12.4 Billion by 2036 as Rising Breast Cancer Incidence Accelerates Drug Innovation
The Breast Cancer Drug Market is expected to maintain steady growth as the global healthcare industry continues to prioritize long-term treatment strategies for breast cancer, particularly hormone receptor-positive (HR+) and HER2-negative disease. According to Future Market Insights (FMI), the market is projected to grow from USD 11.1 billion in 2026 to USD 12.4 billion by 2036, registering a...
0 Commenti 0 condivisioni 6 Views 0 Anteprima